-
Press Room
-
Press Releases
-
Aug 08, 2019
1:45 PM
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer
-
Aug 07, 2019
2:00 PM
VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update
-
Jul 24, 2019
9:15 PM
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
-
Jul 18, 2019
2:15 PM
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
-
Jul 10, 2019
2:15 PM
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
-
May 08, 2019
10:53 AM
VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update
-
May 07, 2019
10:53 AM
VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer
-
May 06, 2019
10:53 AM
VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update
-
Apr 09, 2019
10:53 AM
VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report
-
Apr 09, 2019
10:53 AM
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics
-
Apr 04, 2019
2:00 PM
VolitionRx Limited Extends Clinical Trial Program in Lung Cancer
-
Mar 28, 2019
2:30 PM
VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China
-
Mar 25, 2019
2:00 PM
VolitionRx Limited to Present at Conferences in March & April 2019
-
Mar 15, 2019
2:00 PM
VolitionRx Limited to Present at Conferences in the U.S. Next Week
-
Mar 13, 2019
2:30 PM
VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update
-
Mar 07, 2019
2:00 PM
VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update